NOMAD POWER SOLUTIONS, INC. Debt Instrument, Convertible, Conversion Price
NOMAD POWER SOLUTIONS, INC. (NMAD) had Debt Instrument, Convertible, Conversion Price of $0.71 per share as of 2026-02-28, per its 10-Q filed 2026-05-14.
Financial Statements › Notes
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2026-05-14
- 2026-02-28: Debt Instrument, Convertible, Conversion Price $0.71.
- 2026-01-31: Debt Instrument, Convertible, Conversion Price $0.71.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2026-02-28 | $0.71 10-Q · filed 2026-05-14 |
| 2026-01-31 | $0.71 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |